MBRX - Moleculin Biotech

-

$undefined

N/A

(N/A)

Moleculin Biotech NasdaqCM:MBRX Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses. Its lead drug candidate is Annamycin, which is in Phase 3 clinical trials for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma metastasized to the lungs. The company is also developing WP1066, an immune/transcription modulator designed to inhibit phosphorylated signal transducer and activator of transcription and other oncogenic transcription factors targeting brain tumors, and pancreatic and other cancers. In addition, it develops WP1220, an analog of WP1066 for the topical treatment of cutaneous lymphoma; and WP1122 to treat viruses, as well as cancer indications, including brain tumors, and pancreatic and other cancers. The company was incorporated in 2015 and is headquartered in Houston, Texas.

Location: 5300 Memorial Drive, Houston, TX, 77007, United States | Website: https://moleculin.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

5.435M

Cash

7.716M

Avg Qtr Burn

-5.427M

Short % of Float

7.77%

Insider Ownership

0.71%

Institutional Own.

10.47%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Annamycin + Ara-C (Cytarabine) Details
Blood cancer, Cancer, Acute myeloid leukemia

Phase 3

Data readout

WP1066 Details
Brain tumor, Solid tumor/s, Cancer, Glioblastoma

Phase 1/2

Data readout

Annamycin Details
Soft tissue sarcoma, Solid tumor/s, Cancer, Lung Metastases, Sarcoma

Phase 1/2

Update

WP1122 Details
Cancer, Glioblastoma, Brain tumor, Solid tumor/s

Phase 1/2

Initiation

WP1220 Details
Cutaneous T cell lymphoma, Blood cancer, Cancer, T-cell lymphoma

Phase 1b

Update

WP1066 Details
Cancer, Brain tumor, Solid tumor/s, Glioma

Phase 1

Update

Phase 1a

Update